Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
|Articles|May 31, 2022
Daily OTC Pearl: SinusCalm
Author(s)Saro Arakelians, PharmD
SinusCalm is intended to relieve nasal congestion, sinus pain and pressure, and headache associated with the common cold or allergies.
Advertisement
OTC/Lifestyle Pearl of the Day: SinusCalm
Indication: SinusCalm is intended to relieve nasal congestion, sinus pain and pressure, and headache associated with the common cold or allergies.
Insight:
- Targets sinus pain with a stuffy or runny nose.
- Non-drowsy and doesn’t mask symptoms of a more serious condition.
- Homeopathic multi-symptom sinus relief medicine, non-habit forming with no risk of a rebound effect.
- Slightly sweet pellets that can be dissolved in water for children or seniors.
- Recommended for ages 6 and up.
- Available OTC in a box of 2 multidose tubes for home or on the go (approximately 80 oral pellets per tube).
Source:
Advertisement
Related to this article
The data helps pharmaicts predict who will react strongly to mRNA vaccines—giving them a science-backed talking point during respiratory season.
CDC-recommended adult vaccination programs for pneumococcal disease, RSV, influenza, and COVID-19 prevent over 182,000 deaths and generate up to $12 in societal value for every $1 spent.
This article discusses a recent publication examining pharmacy access across Minnesota and explores the complex factors contributing to threatened community health access across the US.
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
New European Respiratory Society (ERS) update makes sotatercept a strong add-on recommendation, opening a fourth pathway for pharmacists to manage.
At the 2026 New England Institute of Ambulatory Care Pharmacists (NEIAP) Annual Forum, Jennifer Goldman detailed how monitoring data drive engagement—and how a new dual sensor readies pharmacists for ketone alerts.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
2
FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T
3
Radioligand Therapy Doesn’t Need to Be Risk-Free—It Needs to Be Worth It
4
Biologic Stewardship: The Next Frontier for Health System Pharmacists
5